DIA 2013 49th Annual Meeting
Click here to go to the previous page
Where Research, Medicine and Care Converge: A CMO Roundtable Discussion
Track : Track 20: Executive Program
Program Code: 288
Date: Tuesday, June 25, 2013
Time: 4:00 PM to 5:30 PM  EST
Location: 205A
CHAIR :
Michael Rosenblatt, MD (SPKNON), Executive Vice President and Chief Medical Officer, Merck & Co., Inc., United States
SPEAKER (S):
Tim Garnett, MD (SPKNON), Chief Medical Director and Senior Vice President, Eli Lilly and Company, United States
 Richard Schilsky, MD (SPKSUP), Chief Medical Officer, American Society of Clinical Oncology, United States
Edmund Pezalla, Aetna, United States
Valentin Fuster, MD,PhD (SPKSUP), Physician-in-Chief, Mount Sinai Medical Center, United States
Description
Patients today confront challenges that reach far beyond the diagnosis itself, such as what information to believe, understanding that information, and how to apply it to achieve better health. Today's chief medical officers reside squarely at the intersection of innovation, patient advocacy, safety and well being, and communication, and play a unique role in their respective organizations. This panel of chief medical officers will discuss their responsibilities to patients and in improving health care in an evolving landscape.